Can AI transform our healthcare system?
The short answer is: Yes.
The question we should be really asking ourselves here is: How?
How can the healthcare industry benefit from the use of artificial intelligence?
Multiple research studies suggest that:
From enhanced care delivery through AI-assisted diagnostics to medical records management, AI technology is revolutionizing modern healthcare using machines that can learn, understand, predict, and act.
Solve any video or image labeling task 10x faster and with 10x less manual work.
X-ray and computer tomography (CT) are the two trusted means for diagnosing pulmonary diseases.
Such medical imagery provides doctors with life-saving insights which result in better health outcomes.
It takes a great deal of experience to interpret the images properly.
When the patient volumes are high and the timing is critical, doctors need reliable tools that can help them make accurate predictions and act immediately.
That’s where artificial intelligence applications come in handy.
State-of-the-art image recognition algorithms can pick up patterns in X-ray images that are too subtle for the human eye. The machine learning technologies also work at a faster pace—and assist with patient classification and triage.
A group of researchers recently came up with an artificial intelligence solution for screening COVID-19 patients based on their lung X-rays.
The system uses principal component analysis (PCA) and clustering techniques to distinguish between L and H phenotypes of COVID-19.
This AI tool could help healthcare professionals make better treatment decisions: determine whether the patient needs mechanical ventilation to survive (H phenotype) or if applying this treatment could cause lung injury (L phenotype).
The AI solution also helps classify different types of pneumonia (COVID-19 and from other etiologies).
When tested on a patient data sample, the model performed with 92.9% sensitivity (recall) and correctly identified:
Pretty impressive, right?
It’s only a matter of time when more comprehensive patient data will help to advance AI solutions for diagnosing pulmonary diseases.
And speaking of patient data...
We’ve been working on that, too :)
Using AI has proven to be effective in identifying previously undetected cancers on chest X-rays.
Clinical researchers from the Seoul National University Hospital found that a commercially available AI application outperformed a team of four thoracic radiologists on first and second reads.
The tested artificial intelligence algorithm:
The experiment results are promising, but—
Medical professionals still doubt that AI algorithms could produce consistent results in clinical settings when “fed” with larger sample data.
Indeed, the problem of bringing machine learning technology to production is a pressing one for healthcare companies.
Many require modernization of the current software systems before they’d become capable of running advanced machine learning systems. Others need more mature data management and data governance practices to ensure the utmost security of the processed imagery and other patient records.
Skin cancer is one of the most common types of all cancers.
Melanoma may be the rarest subtype, but it will be responsible for over 7000 deaths this year, in the United States alone.
Here’s the better news—
Up to 86% of melanoma skin cancer types are preventable and well-treated if detected at the early stage. As you've probably guessed, artificial intelligence and machine learning can be of help.
Yet, the devil is in the details.
Early-stage melanoma is difficult to distinguish from benign moles and other malignant neoplasms. And that is why doctors are experimenting with AI technology to gain extra decision support.
Commoditized access to cloud computing technologies and active knowledge sharing among machine learning professionals also helped significantly accelerate skin cancer research over the past five years.
Here are some encouraging findings:
In 2019, researchers used a convolutional neural network (CNN), built on InceptionV3 and ResNet50 architectures to analyze close-up and dermoscopic medical imaging datasets.
The goal was to determine non-pigmented skin cancers.
After training the model, they compared how artificial intelligence performed against 95 dermatologists.
What was the result?
The AI delivered the same levels of accuracy as human experts.
The same levels of accuracy.
Let that sink in for a second.
And that’s not all—the tool also performed better than beginner- and intermediate-level dermatologists.
Another scientific group pitted InceptionV4 (a deep learning architecture approved for medical purposes by the European Union) against a group of human dermatologists.
Both were asked to diagnose 100 test cases (including 60 benign and 40 malignant skin lesions) by first reviewing a dermoscopic image and then additional clinical close-up images and clinical information.
Here are the results (with a dermoscopic image only):
With more healthcare information available, the mean sensitivity of humans increased to 94.1%, but the mean specificity stayed the same. However, the CNN system also did slightly better than doctors this time, scoring 95% sensitivity. Yet, more experienced dermatologists did better than an algorithm in many cases.
Now, let’s see how AI can benefit radiology which has long been at the forefront of innovations in the healthcare industry.
This segment is ahead of the adoption curve when it comes to artificial intelligence and machine learning use.
With medical imaging annotation accessibility and quality improving, data scientists in this domain can further enhance the performance levels of the earlier produced artificial intelligence technology.
What’s more, such tools support better decision-making and help doctors win back some precious time, typically spent on image analysis, instead of clinical and laboratory contexts.
Some of the emerging AI use cases in this category include:
To date, the FDA (Food and Drug Administration), has approved over a dozen of deep learning methods for usage in radiology.
Globally, many more AI pilots are moving from the labs to hospital wards.
Here’s the fact: Regular screenings have proven to significantly improve breast cancer survival rates.
Early detection and timely treatments have high efficacy rates. However, the wider introduction of breast cancer screening programs has also placed a higher toll on radiologists.
The European Union Guidelines for breast screening set the aim to invite up to 70%-75 % of eligible women in member states to such programs. With a significant increase in patient volumes, healthcare professionals require smarter support for decision-making. Emerging artificial intelligence solutions proved to deliver such guidance in clinical settings.
A breast clinic at Radboud University Medical Center, on the other hand, recently adopted a tomosynthesis tool to obtain 3D images of the breast, offering a greater level of digitalization for diagnostics.
The trade-off of using such computer-generated images is longer reading time.
Thus, many specialists now rely on artificial intelligence software to facilitate analysis. These tools can process images faster and provide valuable insights for decision-making, empowering radiologists to make evaluations up to 15-20% faster.
Here’s yet another example.
A recent collaboration between Google Health and physicians yielded very promising results.
The group is working on a supporting tool for mammography readings. When put to the test, the AI algorithm was as accurate as a serial reading done by two doctors.
It was the speed, however, that was a significant differentiator—the system reduced the workload of the second reader by 88%.
But speed and accuracy alone won’t solve the bigger problem we are facing, namely—
The rapid increase in the expected shortage of radiologists across the globe.
In fact, the national shortage in the UK already approximates 27-37%, depending on the region. The Association of American Medical Colleges estimated that nearly 42,000 radiology vacancies will remain unfulfilled by 2033.
In developing regions, access to professionals and equipment is even direr. AI systems can reduce the pressure on the healthcare systems and facilitate scaling breast screening and cancer detection programs.
Digital pathology is an emerging sub-division of conventional microscopy, enabling practitioners to virtualize glass pathology slides for more in-depth analysis.
Artificial intelligence algorithms can assist pathologists with:
A group of cancer researchers recently analyzed a public database of WSIs from 11,000 cancer patients, featuring 32 cancer subtypes. The trained algorithm leveraged image data and annotations to reach a “computational consensus” on the type of pathology on display.
The tool identified different types of pathology on frozen section slides with high accuracy:
And performed equally accurately with histopathology slides:
Similar artificial intelligence tools can support clinical decision-making and enhance the diagnosis of lesser studied pathologies and early-stage variations.
So, how about using AI for handling clinical documentation, clinical decision support system, and other electronic health records?
Well, first of all—
Modern artificial intelligence algorithms already saved over $122 billion for early adopters of process automation solutions.
Machine learning and artificial intelligence can be used to automate:
Secondly, natural language processing (NLP), in particular, has proved to drive major productivity gains.
Healthcare providers deal with vast volumes of structured and unstructured patient data that need to be captured in EHR/EMR systems.
The problem, however, is that up to 80% of health data is unstructured, rendering traditional text mining algorithms ineffective. Respectively, a lot of big data in healthcare remains siloed and utilized.
This negatively impacts patient outcomes.
NLP systems can help providers process more information faster, including SDOH data (social determinants of health).
Healthcare professionals say that this data contains important non-clinical insights that impact patients’ well-being and care delivery. But resurfacing it for analysis as it remains siloed across different mediums—spoken notes, patient portals, email exchanges, and EHR systems.
“Medical care is estimated to account for approximately 20% of healthcare outcomes, which is an important reason why healthcare leaders should consider SDOH factors and their impact on patient health.”
—says Dr. Elizabeth Marshall in an interview with Health Tech IT.
According to Marshal, natural language processing algorithms can help access such data and translate it into insights for diagnosis and wider healthcare initiatives. These include care programs, better patient resources, and targeted interventions.
Apart from improving patient outcomes, natural language processing can also help hospitals recoup some operational costs.
Concord hospital has recently adopted Nuance’s AI-powered software suite for speech recognition and real-time clinical records processing. The staff can now dictate notes from any workstation or a personal smartphone, and the data will be auto-transcribed and added to a respective patient file.
The phone-based transcription usage was reduced by 91%, and the instruction recorded a saving of $1 million.
NLP-powered applications can also improve patient care.
Intelligent virtual assistants can converse with patients to collect symptom data while waiting and help identify more critical patients for immediate admissions.
In addition, voice assistants can be more convenient for patients with limited mobility who require a quick consultation or adjustment in their room settings when hospitalized.
Lastly, let’s see how artificial intelligence can be used in ophthalmology.
Research shows that the healthcare systems are experiencing a deeper strain in providing timely ophthalmology care. Due to rapidly aging populations, the public healthcare systems cannot always guarantee timely access to specialists.
This can lead to poor patient outcomes.
Delays in ophthalmology treatment can lead to irreversible harm such as visual field loss and visual acuity deterioration that could have been prevented with earlier diagnosis.
Other types of eye diseases such as diabetic retinopathy (DR), cataract, glaucoma, age-related macular degeneration (AMD) also require timely intervention.
Emerging AI and deep learning models use cases attempt to compensate for gaps in diagnosis and accelerate the providers’ ability to perform population-level screenings.
The growing availability of annotated healthcare datasets and medical imaging serves as a springboard from which new artificial intelligence and computer vision use cases emerge.
Most emerging technologies are yet to be tested in wider clinical settings. Yet—
AI in healthcare has a bright future ahead.
Artificial intelligence, machine learning, and deep learning have proven useful in helping both healthcare providers and patients. Apart from The current (and future) applications include:
It can also analyze data on patient visits to the clinic, medications prescribed, lab tests, and procedures performed in the past.
Theoretical results and early pilots instill great confidence in computer science professionals and doctors joining forces to transform patient care and improve healthcare organizations across the globe.
For AI in healthcare to go mainstream, wider healthcare sector transformations are required, too.
Hospitals will have to invest in new technology systems and staff upskilling. They will need to undertake substantial integration projects, and focus their efforts on the adoption of those technologies in their daily clinical practice.
💡 Read Next: